A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome

Abstract Background Phelan-McDermid syndrome (PMS) is a rare neurodevelopmental disorder caused by haploinsufficiency of the SHANK3 gene and characterized by global developmental delays, deficits in speech and motor function, and autism spectrum disorder (ASD). Monogenic causes of ASD such as PMS ar...

ver descrição completa

Detalhes bibliográficos

Principais autores:	J. Fastman, J. Foss-Feig, Y. Frank, D. Halpern, H. Harony-Nicolas, C. Layton, S. Sandin, P. Siper, L. Tang, P. Trelles, J. Zweifach, J. D. Buxbaum, A. Kolevzon
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-09-01
coleção:	Molecular Autism
Assuntos:	Phelan-McDermid syndrome PMS Shank3 Autism spectrum disorder ASD Oxytocin
Acesso em linha:	https://doi.org/10.1186/s13229-021-00459-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!